Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study

M. Witzens-Harig, R. Foa, A. Di Rocco, Guy Van Hazel, D.F.A. Chamone, J.M Rowe, L. Arcaini, I. Poddubnaya, A.D. Ho, V. Ivanova, A. Vranovsky, D. Thurley, S. Oertel

    Research output: Contribution to journalArticle

    21 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1717-1724
    JournalAnnals of Hematology
    Publication statusPublished - 2014

    Cite this